Spark Biomedical Closes Series A to Advance Wearable Neurostimulation Therapies
Spark Biomedical has raised a Series A round led by WAVE Ventures and Pathway to Cures. The funding will accelerate development of Spark’s bioelectronic therapies across neurological health, hemostasis, and women’s health. The company’s non-invasive technology uses mild electrical pulses to stimulate the vagus and trigeminal nerves, offering drug-free relief by activating the body’s natural healing pathways.
Spark Biomedical Closes Series A to Advance Wearable Neurostimulation Therapies